WHO Malaria Vaccine

WHO Recommends New Vaccine For Malaria

The World Health Organisation (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children, an official release said.

The recommendation follows advice from the WHO: Strategic Advisory Group of Experts on Immunisation (SAGE) and the Malaria Policy Advisory Group (MPAG) and was endorsed by the WHO Director-General following its regular biannual meeting held on September 25-29.

WHO also issued recommendations on the advice of SAGE for new vaccines for dengue and meningitis, along with immunisation schedules and product recommendations for COVID-19.  WHO also issued key immunisation programmatic recommendations on polio, IA2030 and recovering the immunisation programme, it added.

The R21 vaccine is the second malaria vaccine recommended by WHO, following the RTS,S/AS01 vaccine, which received a WHO recommendation in 2021. Both vaccines are shown to be safe and effective in preventing malaria in children and, when implemented broadly, are expected to have a high public health impact. Malaria, a mosquito-borne disease, places a particularly high burden on children in the African Region, where nearly half a million children die from the disease each year, the release said.

Demand for malaria vaccines is unprecedented; however, the available supply of RTS,S is limited.  The addition of R21 to the list of WHO-recommended malaria vaccines is expected to result in sufficient vaccine supply to benefit all children living in areas where malaria is a public health risk. 

“As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two,” said Tedros Adhanom Ghebreyesus, WHO Director-General in a media briefing with Strategic Advisory Group of Experts on Immunisation.

“Demand for the RTS,S vaccine far exceeds supply, so this second vaccine is a vital additional tool to protect more children faster, and to bring us closer to our vision of a malaria-free future,” he added.

Matshidiso Moeti, WHO Regional Director for Africa, emphasised the importance of this recommendation for the continent, saying, “This second vaccine holds real potential to close the huge demand-and-supply gap. Delivered to scale and rolled out widely, the two vaccines can help bolster malaria prevention and control efforts and save hundreds of thousands of young lives in Africa from this deadly disease.”

The next steps for the second recommended malaria vaccine, R21/Matrix-M, include completing the ongoing WHO prequalification which would enable international procurement of the vaccine for a broader rollout.

At least 28 countries in Africa plan to introduce a WHO-recommended malaria vaccine as part of their national immunisation programmes. Gavi, the Vaccine Alliance has approved providing technical and financial support to roll out malaria vaccines to 18 countries. The RTS,S vaccine will be rolled out in some African countries in early 2024, and the R21 malaria vaccine is expected to become available to countries in mid-2024, a WHO release said. (ANI)

Read More: https://lokmarg.com/

primary healthcare India WHO

Covid Global Health Emergency Over: WHO

The World Health Organisation (WHO) has announced that Covid-19 pandemic is over as a global health emergency.

Dr Tedros Adhanom Ghebreyesus, Director-General of WHO, made the announcement while addressing a media briefing on Covid-19 and global health issues.
“It is therefore with great hope that I declare #Covid19 over as a global health emergency. However, that does not mean Covid-19 is over as a global health threat. Last week, Covid-19 claimed a life every three minutes – and that’s just the deaths we know about,” he said.

“As we speak, thousands of people around the world are fighting for their lives in intensive care units. And millions more continue to live with the debilitating effects of post-#Covid19 condition,” the Director General of WHO added.

The WHO had declared Covid-19 as a global emergency in January 2020.

“1221 days ago, WHO learned of a cluster of cases of pneumonia of unknown cause in Wuhan, China. On the 30th January 2020, on the advice of an Emergency Committee convened under the International Health Regulations, I declared a public health emergency of international concern over the global outbreak of #Covid19 – the highest level of alarm under international law,” Tedros said.

“At that time, outside China there were fewer than 100 reported [#Covid19] cases, and no reported deaths. In the 3 years since then, Covid-19 has turned our world upside down. Almost 7 million deaths have been reported to WHO, but we know the toll is several times higher – at least 20 million,” he noted.

“What this news means is that it is time for countries to transition from emergency mode to managing #Covid19 alongside other infectious diseases,” he added. (ANI)

WHO Asks China To Share Data On COVID

WHO Asks China To Share Real-Time Data On COVID Situation

World Health Organization chief Tedros Adhanom Ghebreyesus met with Chinese officials and again asked for specific and real-time data on the epidemiological situation in China, according to the statement released by the WHO website.

In the high-level meeting, WHO asked for more genetic sequencing data, data on disease impact including hospitalizations, intensive care unit (ICU) admissions and deaths — and data on vaccinations delivered and vaccination status, especially in vulnerable people and those over 60 years old.
WHO reiterated the importance of vaccination and boosters to protect against severe disease and death for people at higher risk.

China’s National Health Commission and the National Disease Control and Prevention Administration briefed WHO on China’s evolving strategy and actions in the areas of epidemiology, monitoring of variants, vaccination, clinical care, communication, and R&D.

During the meeting, WHO called on China to strengthen its clinical management and impact assessment, and expressed willingness to provide support in these areas, as well as on risk communications on vaccination to counter hesitancy. WHO also invited Chinese Scientists to engage more closely in COVID-19 expert networks including clinical management. WHO has invited Chinese scientists to present detailed data on viral sequencing at a meeting of the Technical Advisory Group on SARS-CoV-2 Virus Evolution on January 3, according to the statement.

“WHO stressed the importance of monitoring and the timely publication of data to help China and the global community to formulate accurate risk assessments and to inform effective responses,” the statement reads.

Earlier, on Thursday, Ghebreyesus held a press conference and said that the global body remains concerned over the evolving situation in China as COVID-19 infections witness a new spike in the country after curbs were eased.

Tedros said that the WHO will continue to offer its support for clinical care and protect the shattering healthcare system of China.

“We remain concerned about the evolving situation and continue encouraging #China to track the #COVID19 virus and vaccinate the highest risk people. We continue to offer our support for clinical care and protecting its health system,” Tedros wrote on Twitter.

Regarding the travel restrictions and guidelines issued by several countries for travellers from China, Tedros said that due to the unavailability of an apt amount of information from China about the outbreak, it is understandable that countries around the world are acting in such ways.

“In the absence of comprehensive information from #China, it is understandable that countries around the world are acting in ways that they believe may protect their populations. #COVID19,” Tedros tweeted. (ANI)

Read More: http://13.232.95.176